Search - tctmd.com

Displaying 661 - 680 of 947

Sort: Relevancy | Date

Presentation TCT 2021

Transseptal Transcatheter Mitral Valve Chordal Repair Using the CardioMech Valve Repair System: Early First in Human Experience

Presenter: Michael Joseph Rinaldi

November 04, 2021

Presentation TCT 2021

Featured Lecture: Air Embolism During Large Bore Cardiovascular Procedures- The Big Elephant in the Room

Presenter: Tilo Kölbel

November 04, 2021

Presentation TCT 2021

Cerebral Protection in TAVR: The PROTEMBO C Trial

Presenter: Tobias Schmidt

November 04, 2021

Presentation TCT 2021

LAA Closure with the Laminar Device: technology and Clinical Update

Presenter: Jason H. Rogers

November 04, 2021

World’s First Dedicated 3D Sizing LAA Exclusion Device (Paladin Medical’s Trinity System)

Presentation TCT 2021

Introducing XCLUDE Integrated Solution. World's First Dedicated LAA 3D Sizing Device and Next-Gen LAA Exclusion Device

Presenter: Flavio Airoldi

November 04, 2021

Presentation TCT 2021

Next Generation LAA Exclusion System to Reduce Stroke Risk in AF Patients (Append)

Presenter: Zachi Berger

November 04, 2021

Presentation TCT 2021

Featured Lecture: Clinical Outcomes of LAAO versus NOACS in Atrial Fibrillation in Patients with Prior Ischemic Stroke: Is There Room for Improvement in Clinical Outcomes?

Presenter: Jens Erik Nielsen-Kudsk

November 04, 2021

Presentation TCT 2021

Novel Transcatheter Tricuspid Valve Devices: A Lens Into the Future

Presenter: Azeem Latib

November 04, 2021

Presentation TCT 2021

Controversies Surrounding Transcatheter Devices: Durability, Anticoagulation, Conduction, and More

Presenter: Josep Rodés-Cabau

November 04, 2021

Presentation TCT 2021

Transcatheter Replacement Devices Will Be the Dominant Solution

Presenter: Firas Zahr

November 04, 2021

Presentation TCT 2021

Transcatheter Repair Devices Will Be the Dominant Solution

Presenter: Jörg Hausleiter

November 04, 2021

Presentation TCT 2021

HALT: Long-Term Clinical Impact of Hypoattenuating Leaflet Thickening After TAVR

Presenter: Santiago Garcia

November 04, 2021

Presentation TCT 2021

Outcomes of Repeat TAVR According to the Initial and Subsequent TAVR Type

Presenter: Uri Landes

November 04, 2021

Presentation TCT 2021

Outcomes of Repeat TAVR With Balloon-Expandable Sapien 3/Ultra Valves

Presenter: Raj Makkar

November 04, 2021

News Daily News

Tendyne at 2 Years: Confirmed Feasibility but High Mortality With TMVR

Yael L. Maxwell

November 03, 2021

News Daily News

Tailored TAVI: Standardizing Balloon Pressures May Curb Operator Angst

L.A. McKeown

October 28, 2021

News Opinion Off Script

Restarting In-Person Interventional Meetings: A Delicate but Necessary Juggling Act

Juan F. Granada, MD

October 14, 2021

News Opinion CV Team Dispatch

October 2021 News Roundup

L.A. McKeown

October 01, 2021

News Daily News

Few TAVI Doctors Are Women, With No Female Operators in 19 States

Yael L. Maxwell

September 29, 2021

#TAVR Case Reports on Twitter Paint Overly Optimistic Picture

News Daily News

#TAVR Case Reports on Twitter Paint Rosy Picture

Caitlin E. Cox

July 21, 2021

Advertisement

Transseptal Transcatheter Mitral Valve Chordal Repair Using the CardioMech Valve Repair System: Early First in Human Experience

Featured Lecture: Air Embolism During Large Bore Cardiovascular Procedures- The Big Elephant in the Room

Cerebral Protection in TAVR: The PROTEMBO C Trial

LAA Closure with the Laminar Device: technology and Clinical Update

Introducing XCLUDE Integrated Solution. World's First Dedicated LAA 3D Sizing Device and Next-Gen LAA Exclusion Device

Next Generation LAA Exclusion System to Reduce Stroke Risk in AF Patients (Append)

Featured Lecture: Clinical Outcomes of LAAO versus NOACS in Atrial Fibrillation in Patients with Prior Ischemic Stroke: Is There Room for Improvement in Clinical Outcomes?

Novel Transcatheter Tricuspid Valve Devices: A Lens Into the Future

Controversies Surrounding Transcatheter Devices: Durability, Anticoagulation, Conduction, and More

Transcatheter Replacement Devices Will Be the Dominant Solution

Transcatheter Repair Devices Will Be the Dominant Solution

HALT: Long-Term Clinical Impact of Hypoattenuating Leaflet Thickening After TAVR

Outcomes of Repeat TAVR According to the Initial and Subsequent TAVR Type

Outcomes of Repeat TAVR With Balloon-Expandable Sapien 3/Ultra Valves

Tendyne at 2 Years: Confirmed Feasibility but High Mortality With TMVR

Tailored TAVI: Standardizing Balloon Pressures May Curb Operator Angst

Restarting In-Person Interventional Meetings: A Delicate but Necessary Juggling Act

October 2021 News Roundup

Few TAVI Doctors Are Women, With No Female Operators in 19 States

#TAVR Case Reports on Twitter Paint Rosy Picture

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content